Hilton Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.79M Buy
10,638
+244
+2% +$247K 0.74% 32
2025
Q4
$11.2M Buy
10,394
+30
+0.3% +$28.7K 0.84% 27
2025
Q3
$7.91M Sell
10,364
-802
-7% -$597K 0.64% 38
2025
Q2
$8.7M Sell
11,166
-4,069
-27% -$3.16M 0.69% 38
2025
Q1
$12.6M Buy
15,235
+35
+0.2% +$29.1K 1.07% 19
2024
Q4
$11.7M Sell
15,200
-1,870
-11% -$1.55M 1.02% 28
2024
Q3
$15.1M Buy
17,070
+258
+2% +$232K 1.17% 18
2024
Q2
$15.2M Buy
16,812
+4,012
+31% +$3.21M 1.28% 19
2024
Q1
$9.96M Sell
12,800
-662
-5% -$471K 0.89% 36
2023
Q4
$7.85M Buy
13,462
+895
+7% +$522K 0.84% 37
2023
Q3
$6.75M Buy
+12,567
New +$6.48M 0.9% 33

Other funds holding LLY

Hilton Capital Management's LLY Position: Q1 2026 in Review

Hilton Capital Management increased its Eli Lilly (LLY) stake by 2.3% in Q1 2026, buying an estimated $247K and bringing the position to 10,638 shares worth $9.79M. The position accounts for 0.74% of the portfolio, ranked #32.

Hilton Capital Management first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $15.2M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Hilton Capital Management held 10,638 shares of Eli Lilly worth $9.79M as of Q1 2026.
  • Hilton Capital Management bought 244 Eli Lilly shares in Q1 2026, an estimated $247K.
  • Eli Lilly made up 0.74% of Hilton Capital Management's portfolio in Q1 2026, its #32 holding.
  • Hilton Capital Management first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • Hilton Capital Management's Eli Lilly position peaked at $15.2M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Hilton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.